Explore the latest in oncology, including recent guidelines and advances in the screening, diagnosis, and treatment of breast and lung cancer.
This cohort study examines the use of ultrasonography in an active surveillance program to suggest continued surveillance vs surgery in patients with low-risk papillary thyroid cancer.
This dynamic cohort study evaluates the regional adoption of genomic testing for prostate cancer and the common trajectories of uptake shared by regions.
This meta-analysis reviews 21 trials of stereotactic ablative radiotherapy administered to patients with oligometastatic cancer.
This Viewpoint discusses the cardiotoxicity of ibrutinib and the need for further research and postmarketing regulation.
This cross-sectional study assesses how patients with cancer perceive cancer treatment and follow-up care (including experiences with telephone and video consultations) and patients’ well-being in comparison with a norm population during the COVID-19 pandemic.
This Medical News article discusses updates in the American Cancer Society’s cervical cancer screening guideline.
This cohort study uses UK Biobank data to estimate the risk for primary hepatic carcinoma and cancer-related death by HFE variant status among community-dwelling individuals of European ancestry in England, Scotland, and Wales.
This economic evaluation modeled the cost-effectiveness of 5 neoadjuvant-adjuvant treatment strategies for women with ERBB2-positive breast cancer.
This cross-sectional study examines associations among brain volume, brain network connectivity, and neurocognitive test performance in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
This cohort study evaluates the association of different adjuvant therapies with survival outcomes in patients with triple-negative breast cancer.
This cohort study evaluates whether machine learning models could identify patients with intermediate-risk head and neck squamous cell carcinoma who would benefit from chemoradiation.
This nested case-control study evaluates the association between duration and recency of low-dose aspirin use and colorectal cancer risk in an East Asian population.
This systematic review and meta-analysis uses data from studies retrieved from a Cochrane Library, ScienceDirect, PubMed, and Embase search to investigate the association of circulating tumor DNA with disease-free survival in patients with breast cancer.
This Viewpoint argues that specialty generics can cost more for patients than brand-name drugs, and proposes strategies to protect patients by addressing the market dysfunction caused by rebates.
This single-arm, phase 2 nonrandomized clinical trial assesses the efficacy and safety of combined pembrolizumab, bevacizumab, and oral metronomic cyclophosphamide in women with recurrent platinum-sensitive, platinum-resistant, or refractory epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: